Type of Posting: Notice of Intent to Revise
Posting Date: 26–Apr–2024
Targeted Official Date: 01–Dec–2024
Expert Committee: Various
In accordance with the Rules and Procedures of the Council of Experts, this is to provide notice that USP intends to revise the Chemical Information of select standards in accordance with the General Announcement published on March 25, 2022.
USP is scheduled to publish Chemical Information updates on June 3, 2024. The updated standards are expected to become official on December 1, 2024. The changes will be highlighted in yellow and followed by the notation (CN 1-Dec-2024) in the updated standards.
The impacted standards are as follows:
- Balsalazide Disodium (USP Monograph)
- Balsalazide Disodium Capsules (USP Monograph)
- Fluticasone Propionate Nasal Spray (USP Monograph)
- Diltiazem Hydrochloride (USP Monograph)
- Diltiazem Hydrochloride Extended-Release Capsules (USP Monograph)
- Diltiazem Hydrochloride Tablets (USP Monograph)
- Quetiapine Fumarate (USP Monograph)
- Terazosin Hydrochloride (USP Monograph)
Should you have any questions, please contact Elena Gonikberg, Sr. Principal Scientist (eg@usp.org).